Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Chocolate maker, The Hershey Company ( HSY - Analyst Report ) posted second quarter 2012 adjusted earnings of 66 cents a share, beating the Zacks Consensus Estimate of 61 cents by 8%. Also, earnings rose 17.9% from the prior-year quarter, driven by revenue growth and improved gross margins in spite of rising input costs and a difficult macro-economic environment.
Quarter in Detail
Hershey’s net sales of $1.41 billion rose 6.7% from the prior-year quarter, mainly buoyed by increased pricing. Benefits from pricing (6.6 percentage points) and the January 2012 acquisition of Canadian confectionary company Brookside Foods (2.4 points) were partially offset by volume declines (1.1 points) and foreign exchange headwinds (1.2 points). Quarterly sales however barely missed the Zacks Consensus Revenue Estimate of $1.42 billion.
Hershey’s is one of the largest U.S. confectioners and is well known for chocolate products like Hershey’s, Reese’s, and Kisses, as well as non-chocolate confectioneries, such as Jolly Rancher candy, Ice Breakers chewing gum, Breath Savers mints, and Bubble Yum bubble gum.
Hershey’s adjusted gross margin for the quarter expanded 170 basis points (bps) to 44.8%, as pricing and productivity benefits and improved efficiencies from supply chain initiatives offset headwinds from rising input costs.
Selling, marketing and administrative expenses (SM&A), excluding advertising, increased at a mid-teens rate in the second quarter of 2012 due to increased investments in marketing in both the U.S. and internationally. Advertising spend increased 10% over the prior-year quarter as the company continued with its aggressive marketing efforts for established as well as newly launched brands worldwide. Operating margin expanded 40 bps in the quarter to 17.5%.
Outlook
For 2012, the company expects to record adjusted earnings in the range of $3.17–$3.23 per share, up from the prior forecast of $3.11–$3.17 per share on improved gross margins. The guidance mainly excludes acquisition/integration costs related to the Brookside acquisition and expenses related to Hershey’s supply chain and cost savings program, Project Next Century. Overall, adjusted earnings per share are expected to grow in the range of 12–14% year over year versus the prior expectation of growth in the range of 10–12%.
The 2012 net sales growth guidance (including the impact of foreign currency) was maintained at 7%-9%. The guidance includes a 1.5 percentage point benefit from the Brookside acquisition. Organic volume is expected to be up for 2012 as it accelerates in the second half of the year. Management expects price and volume to contribute in a more balanced manner for the rest of 2012.
For 2012, gross margins are expected to expand between 100–120 basis points year over year, up from prior expectations of an increase of 90–100 basis points. Expansion in gross margins will be on the back of pricing gains despite the higher input costs.
As previously guided, advertising expenses (as a percentage of revenue) are expected to increase in low double digits in 2012 as the company increases season-specific advertising, invests in core brand marketing, launches new products and supports the rollout of new brands like Jolly Rancher Crunch ‘N Chew candy, Ice Breakers Duo mints, Rolo Minis and Hershey’s Simple Pleasures chocolates. SM&A expenses, excluding advertising, are expected to rise in a mid-teens percentage for the remaining quarters of 2012, as the company expands internationally and invests in market research, category management, and building/selling capabilities.
Our Recommendation
We currently have a Neutral recommendation on The Hershey Company. The stock carries a Zacks #3 Rank in the near term (‘Hold’ rating).
We are impressed by the company’s second quarter performance. Hershey’s strong brand positioning, strategic marketing investments in core brands, disciplined innovation, and consumer capabilities make it attractive. However, higher ingredient costs and lack of significant presence outside U.S. keep us on the sidelines.
Read the full reports :
Analyst Report on HSY